Skip to main content
logo
Alivus Life Sciences Limited (BOM:543322)
India flag India · Delayed Price · Currency is INR
1,056.55
-13.85 (-1.29%)
At close: May 29, 2026

Alivus Life Sciences Revenue

In the fiscal year ending March 31, 2026, Alivus Life Sciences had annual revenue of 25.52B INR with 6.91% growth. Alivus Life Sciences had revenue of 6.89B in the quarter ending March 31, 2026, with 6.09% growth.

Revenue
25.52B
Revenue Growth
+6.91%
P/S Ratio
5.08
Revenue / Employee
11.58M
Employees
2,203
Market Cap
129.55B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202625.52B1.65B6.91%
Mar 31, 202523.87B1.04B4.54%
Mar 31, 202422.83B1.22B5.64%
Mar 31, 202321.61B380.06M1.79%
Mar 31, 202221.23B2.38B12.63%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
IOL Chemicals and Pharmaceuticals23.19B
Neuland Laboratories20.23B
Shilpa Medicare15.49B
Bajaj HealthCare6.11B
NGL Fine-Chem5.01B
Sai Parenteral's3.81B
Anlon Healthcare1.72B
Gujarat Themis Biosyn1.66B
Revenue Rankings

Alivus Life Sciences News

More News